Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OK › Tulsa › NPI 1104560945
Lab

Labcorp Oklahoma, INC.

Labcorp Oklahoma, INC. was paid $7.77M by Medicaid between Oct 2022 and Dec 2024, across 233 billing codes. Its largest line is 80050, General health panel — 8.3% of everything it billed.

33Billing provider infoLABCORP OKLAHOMA, INC.
TULSA, OK 74146
33aNPI1104560945assigned 04/27/2022
33bProvider typeClinical Medical Laboratory
28Total paid$7.77M
24GClaims557,306
24DCodes billed233
24AFirst – last monthOct 2022 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Oklahoma

Rank by total paid#5 of 46
Median peer was paid$248K
This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202273,605$1.09M
2023308,320$4.33M
2024incomplete175,381$2.35M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80050 General health panel 8.3% 21,373 21,316 $649K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 6.0% 15,320 14,986 $470K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 6.0% 15,340 15,004 $467K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 4.0% 4,370 4,306 $310K
80061 Lipid panel 3.9% 26,235 26,118 $305K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.5% 5,054 4,895 $272K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.2% 37,462 34,443 $247K
80053 Comprehensive metabolic panel 3.1% 26,713 25,038 $238K
87481 2.9% 7,509 4,455 $227K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2.8% 7,145 7,018 $219K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2.8% 8,405 8,362 $216K
83036 Hemoglobin; glycosylated (A1C) 2.4% 21,548 21,446 $183K
221 more codes
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.3% 8,446 $177K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.2% 3,567 $171K
87086 Culture, bacterial; quantitative colony count, urine 2.0% 22,573 $159K
84443 Thyroid stimulating hormone (TSH) 2.0% 10,783 $153K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.0% 4,958 $152K
86481 1.5% 1,281 $113K
86780 1.3% 8,720 $101K
87070 1.2% 12,743 $96K
87077 1.1% 12,585 $89K
82728 1.1% 7,270 $86K
84439 1.1% 10,891 $85K
84403 1.0% 3,491 $79K
86803 <1% 6,181 $76K
80074 <1% 1,693 $68K
83880 <1% 1,964 $67K
87340 <1% 7,200 $65K
86762 <1% 5,063 $62K
84481 <1% 3,909 $57K
87186 <1% 7,300 $56K
83970 <1% 1,493 $53K
82670 <1% 2,177 $53K
87902 <1% 218 $49K
86850 <1% 5,604 $48K
83550 <1% 6,143 $47K
84702 <1% 3,633 $46K
83540 <1% 7,091 $40K
86235 <1% 1,717 $39K
86038 <1% 3,625 $38K
87522 Neg quan hep c or qual rna <1% 1,002 $37K
83001 <1% 2,183 $35K
87081 <1% 6,018 $35K
84153 <1% 2,106 $34K
84270 <1% 1,767 $34K
82607 <1% 2,519 $33K
84144 <1% 1,794 $32K
86376 <1% 2,471 $31K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 48 $30K
80048 Basic metabolic panel (calcium, ionized) <1% 3,894 $28K
83735 <1% 4,792 $28K
83002 <1% 1,702 $27K
85055 <1% 861 $27K
86140 <1% 5,852 $27K
86696 <1% 1,516 $26K
82043 <1% 4,827 $24K
86706 <1% 2,528 $24K
83655 <1% 2,206 $23K
36415 Collection of venous blood by venipuncture <1% 4,661 $22K
87529 <1% 684 $22K
86704 <1% 2,042 $22K
86039 <1% 2,075 $20K
82746 <1% 1,550 $20K
86160 <1% 1,462 $19K
86800 <1% 1,354 $19K
86258 <1% 1,033 $19K
84146 <1% 1,101 $19K
82784 <1% 1,533 $19K
86665 <1% 1,125 $19K
86695 <1% 1,484 $17K
84480 <1% 1,378 $17K
82950 <1% 4,169 $17K
84425 <1% 904 $17K
87205 <1% 4,529 $17K
87510 <1% 965 $17K
87480 <1% 978 $17K
87660 <1% 926 $16K
87899 <1% 1,076 $16K
85027 <1% 2,779 $16K
86225 <1% 1,303 $16K
84436 <1% 2,567 $16K
86708 <1% 1,395 $15K
85652 <1% 6,405 $15K
81001 <1% 5,323 $15K
80076 <1% 2,057 $15K
82105 <1% 1,029 $14K
83525 <1% 1,444 $14K
86900 <1% 5,309 $14K
86901 <1% 5,268 $14K
86709 <1% 1,379 $14K
84550 <1% 3,256 $13K
87536 <1% 168 $13K
84100 <1% 2,890 $12K
85610 <1% 3,166 $12K
83615 <1% 2,178 $11K
86431 <1% 2,304 $11K
87279 <1% 727 $11K
84207 <1% 429 $11K
82570 <1% 2,335 $10K
86200 <1% 916 $10K
87075 <1% 1,246 $10K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 103 $10K
86003 <1% 429 $10K
82550 <1% 1,605 $9K
82951 <1% 805 $9K
83520 <1% 575 $9K
84482 <1% 641 $9K
83690 <1% 1,390 $8K
86757 <1% 484 $8K
82672 <1% 436 $8K
84446 <1% 649 $8K
82120 <1% 1,592 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 261 $8K
84156 <1% 2,404 $8K
86664 <1% 569 $8K
84597 <1% 611 $7K
80069 <1% 953 $7K
84466 <1% 633 $7K
87210 <1% 1,380 $7K
84630 <1% 678 $7K
82785 <1% 480 $7K
84590 <1% 656 $7K
87799 <1% 180 $7K
83993 <1% 393 $7K
86663 <1% 571 $6K
82533 <1% 457 $6K
86677 <1% 406 $6K
80164 <1% 493 $6K
82274 <1% 428 $6K
86255 <1% 522 $6K
86364 <1% 559 $6K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 32 $6K
87046 <1% 656 $5K
87045 <1% 654 $5K
87147 <1% 1,152 $5K
82248 <1% 1,156 $5K
86362 <1% 502 $5K
82677 <1% 224 $5K
86787 <1% 412 $5K
87338 <1% 383 $5K
87102 <1% 627 $5K
82627 <1% 237 $4K
82247 <1% 980 $4K
84165 <1% 452 $4K
83986 <1% 1,382 $4K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 49 $4K
86147 <1% 94 $4K
81003 <1% 2,134 $4K
85730 <1% 765 $4K
86060 <1% 638 $4K
86666 <1% 246 $4K
82024 <1% 117 $4K
86618 <1% 281 $4K
82150 <1% 674 $4K
86317 <1% 54 $4K
85045 <1% 1,084 $4K
82977 <1% 585 $4K
84681 <1% 203 $4K
80197 <1% 331 $4K
85007 <1% 1,064 $4K
87209 <1% 217 $3K
84703 <1% 499 $3K
87015 <1% 561 $3K
86336 <1% 228 $3K
84479 <1% 549 $3K
84134 <1% 239 $3K
83521 <1% 201 $3K
87185 <1% 622 $3K
86668 <1% 239 $3K
82952 <1% 747 $3K
87449 <1% 232 $2K
87328 <1% 202 $2K
80178 <1% 401 $2K
82652 <1% 68 $2K
84154 <1% 139 $2K
86146 <1% 50 $2K
85379 <1% 230 $2K
87329 <1% 190 $2K
86592 <1% 478 $2K
87324 <1% 168 $2K
86036 <1% 169 $2K
84402 <1% 80 $2K
85018 <1% 827 $2K
85014 <1% 814 $2K
81025 <1% 227 $2K
80177 <1% 138 $2K
87177 <1% 189 $1K
86360 <1% 30 $1K
82681 <1% 51 $1K
84155 <1% 354 $1K
84484 <1% 94 $1K
83013 <1% 17 $1K
87076 <1% 140 $990.21
86644 <1% 73 $908.80
87625 <1% 25 $901.75
81015 <1% 322 $858.91
84432 <1% 60 $771.66
87517 <1% 20 $762.20
86769 <1% 19 $752.48
82140 <1% 58 $725.76
86256 <1% 64 $700.84
86308 <1% 147 $659.69
86361 <1% 26 $619.32
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 39 $588.80
82787 <1% 30 $584.66
82653 <1% 28 $572.04
83498 <1% 25 $544.97
86880 <1% 96 $516.40
84445 <1% 12 $505.30
86359 <1% 15 $503.40
87808 <1% 38 $503.20
82378 <1% 28 $470.70
83883 <1% 37 $447.70
86008 <1% 30 $441.47
83721 <1% 45 $411.93
87254 <1% 12 $400.20
86645 <1% 28 $392.30
83020 <1% 28 $306.64
80175 <1% 26 $294.75
86304 <1% 13 $240.63
82390 <1% 25 $219.15
85705 <1% 24 $200.57
87101 <1% 26 $178.36
89055 <1% 46 $164.79
84460 <1% 32 $150.72
86705 <1% 14 $146.58
83010 <1% 13 $145.47
82103 <1% 12 $143.40
87184 <1% 20 $121.68
85613 <1% 16 $119.28
82947 <1% 28 $94.50
85660 <1% 12 $53.90
84520 <1% 12 $42.12

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.